DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,931,955 | +2.3% | 7,787 | -1.0% | 0.25% | +2.5% |
| Q2 2023 | $1,887,600 | -4.8% | 7,865 | -0.1% | 0.24% | -6.2% |
| Q1 2023 | $1,983,303 | -6.1% | 7,869 | -1.1% | 0.26% | -12.0% |
| Q4 2022 | $2,112,478 | +3.0% | 7,959 | +0.3% | 0.29% | -12.0% |
| Q3 2022 | $2,050,000 | +1.8% | 7,937 | -0.1% | 0.33% | +7.8% |
| Q2 2022 | $2,014,000 | -12.4% | 7,944 | +1.3% | 0.31% | -10.7% |
| Q1 2022 | $2,300,000 | -11.0% | 7,840 | -0.2% | 0.34% | -9.7% |
| Q4 2021 | $2,585,000 | -8.8% | 7,858 | -15.6% | 0.38% | -11.8% |
| Q3 2021 | $2,835,000 | +12.5% | 9,313 | -0.9% | 0.43% | +1.6% |
| Q2 2021 | $2,521,000 | +56.5% | 9,394 | +31.3% | 0.43% | -37.6% |
| Q1 2021 | $1,611,000 | +4.0% | 7,157 | +2.6% | 0.68% | -1.3% |
| Q4 2020 | $1,549,000 | +3.1% | 6,974 | -0.1% | 0.69% | +16.5% |
| Q3 2020 | $1,503,000 | +21.8% | 6,979 | 0.0% | 0.59% | +12.5% |
| Q2 2020 | $1,234,000 | +27.9% | 6,979 | +0.1% | 0.53% | +10.9% |
| Q1 2020 | $965,000 | -12.4% | 6,975 | -2.8% | 0.48% | +11.2% |
| Q4 2019 | $1,101,000 | +34.1% | 7,175 | +26.2% | 0.43% | +17.3% |
| Q3 2019 | $821,000 | +1.1% | 5,685 | +0.1% | 0.36% | -0.3% |
| Q2 2019 | $812,000 | +8.1% | 5,681 | -0.1% | 0.37% | +10.9% |
| Q1 2019 | $751,000 | +28.2% | 5,687 | 0.0% | 0.33% | +16.2% |
| Q4 2018 | $586,000 | -5.2% | 5,687 | 0.0% | 0.28% | +10.1% |
| Q3 2018 | $618,000 | +10.2% | 5,687 | 0.0% | 0.26% | +3.6% |
| Q2 2018 | $561,000 | +3.5% | 5,687 | +2.7% | 0.25% | -0.8% |
| Q1 2018 | $542,000 | +5.4% | 5,538 | 0.0% | 0.25% | +11.1% |
| Q4 2017 | $514,000 | +8.2% | 5,538 | -0.1% | 0.23% | -2.6% |
| Q3 2017 | $475,000 | +0.6% | 5,541 | -1.0% | 0.23% | -3.7% |
| Q2 2017 | $472,000 | -0.4% | 5,595 | +1.0% | 0.24% | -2.4% |
| Q1 2017 | $474,000 | +10.0% | 5,541 | 0.0% | 0.25% | +9.3% |
| Q4 2016 | $431,000 | -0.7% | 5,541 | 0.0% | 0.23% | -4.2% |
| Q3 2016 | $434,000 | -22.5% | 5,541 | 0.0% | 0.24% | -24.1% |
| Q2 2016 | $560,000 | +6.5% | 5,541 | 0.0% | 0.31% | +6.5% |
| Q1 2016 | $526,000 | +1.9% | 5,541 | -0.2% | 0.29% | +1.7% |
| Q4 2015 | $516,000 | +20.6% | 5,551 | +10.5% | 0.29% | +11.2% |
| Q3 2015 | $428,000 | -0.5% | 5,025 | 0.0% | 0.26% | +4.9% |
| Q2 2015 | $430,000 | -1.1% | 5,025 | -2.0% | 0.25% | -9.9% |
| Q1 2015 | $435,000 | +3854.5% | 5,125 | +4000.0% | 0.27% | +3800.0% |
| Q4 2014 | $11,000 | +22.2% | 125 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $9,000 | -10.0% | 125 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $10,000 | +11.1% | 125 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $9,000 | -10.0% | 125 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $10,000 | +11.1% | 125 | 0.0% | 0.01% | -14.3% |
| Q3 2013 | $9,000 | +12.5% | 125 | 0.0% | 0.01% | +16.7% |
| Q2 2013 | $8,000 | -60.0% | 125 | -61.5% | 0.01% | -72.7% |
| Q1 2013 | $20,000 | +11.1% | 325 | 0.0% | 0.02% | 0.0% |
| Q4 2012 | $18,000 | – | 325 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |